Ftse Mib
33.840,28
1,07%
DAX
18.247,38
0,52%
S&P 500
5.509,01
0,62%
NASDAQ
18.028,76
0,84%
Bitcoin
60.787,72
-2,00%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Apyx Medical Corporation (APYX) Apyx Medical Corporation (APYX) Notizie

APYX

Apyx Medical (APYX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APYX
DataOraFonteTitoloSimboloCompagnia
26/06/202413:30PR Newswire (US)Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental HealthNASDAQ:APYXApyx Medical Corporation
31/05/202420:49Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:APYXApyx Medical Corporation
09/05/202418:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APYXApyx Medical Corporation
09/05/202416:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
09/05/202413:45Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:APYXApyx Medical Corporation
09/05/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APYXApyx Medical Corporation
09/05/202413:05Business WireApyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
09/05/202413:00Business WireApyx Medical Corporation Announces Board Leadership TransitionNASDAQ:APYXApyx Medical Corporation
25/04/202413:30Business WireApyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:APYXApyx Medical Corporation
11/04/202413:30Business WireApyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ SummitNASDAQ:APYXApyx Medical Corporation
21/03/202412:00Business WireApyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial OutlookNASDAQ:APYXApyx Medical Corporation
04/03/202413:30Business WireApyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024NASDAQ:APYXApyx Medical Corporation
21/02/202413:30Business WireApyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific MeetingNASDAQ:APYXApyx Medical Corporation
14/02/202423:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APYXApyx Medical Corporation
23/01/202415:52Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:APYXApyx Medical Corporation
22/01/202413:30Business WireApyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the BodyNASDAQ:APYXApyx Medical Corporation
11/01/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APYXApyx Medical Corporation
08/01/202413:00Business WireApyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue ResultsNASDAQ:APYXApyx Medical Corporation
28/11/202314:30Business WireApyx Medical Corporation Appoints Matthew Hill as Chief Financial OfficerNASDAQ:APYXApyx Medical Corporation
16/11/202323:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:APYXApyx Medical Corporation
09/11/202313:01Business WireApyx Medical Corporation Announces New Debt Facility with Perceptive AdvisorsNASDAQ:APYXApyx Medical Corporation
09/11/202313:00Business WireApyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial OutlookNASDAQ:APYXApyx Medical Corporation
07/11/202313:30Business WireApyx Medical Corporation to Participate in Upcoming Investor Conferences in NovemberNASDAQ:APYXApyx Medical Corporation
02/10/202313:30Business WireApyx Medical Corporation to Release Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023NASDAQ:APYXApyx Medical Corporation
10/08/202322:05Business WireApyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial OutlookNASDAQ:APYXApyx Medical Corporation
29/06/202322:42Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:APYXApyx Medical Corporation
29/06/202322:42Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:APYXApyx Medical Corporation
29/06/202322:05Business WireApyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023NASDAQ:APYXApyx Medical Corporation
28/06/202320:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APYXApyx Medical Corporation
21/06/202316:54Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:APYXApyx Medical Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:APYX

La tua Cronologia

NASDAQ
SPKLU
Spark I Acquisition
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network